Vigneswaran HT, Palsdottir T, Micoli C, Tilki D, et al. Stockholm3 Versus Prostate-specific Antigen in Prostate Cancer Screening: 9-year Outcomes Demonstrating Improved Detection of Aggressive Cancers and Reduced Overdiagnosis from the STHLM3 Trial. Eur Urol 2025 Oct 16:S0302-2838(25)04735-9. doi: 10.1016/j.eururo.2025.
PMID: 41107178